1,2; Lanfang Xu, MS3; Jin Qin, ScD2; Erin E. Hahn, PhD4; Quyen Ngo-Metzger, MD4,5; Brian Mittman, PhD4; Devansu Tewari, MD6; Melissa Hodeib, DO7; Patricia Wride6; Mona Saraiya, MD2; Chun R.
Chao, PhD4 (View author affiliations)Cancer screening rates, including cervical cancer screening rates, have declined during the COVID-19 pandemic.During California’s stay-at-home order, cervical cancer screening rates among approximately 1.5 million women in the Kaiser Permanente Southern California (KPSC) network decreased approximately 80% compared with baseline.
The decrease was similar across all racial/ethnic groups of KPSC and returned to near normal after reopening.Sustained disruptions could lead to increased risk for cervical cancers and.